A detailed history of Ancora Advisors, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Ancora Advisors, LLC holds 108 shares of DXCM stock, worth $12,245. This represents 0.0% of its overall portfolio holdings.

Number of Shares
108
Previous 108 -0.0%
Holding current value
$12,245
Previous $13,000 7.69%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$112.47 - $130.98 $899 - $1,047
8 Added 8.0%
108 $13,000
Q1 2023

May 15, 2023

SELL
$104.0 - $122.92 $624 - $737
-6 Reduced 5.66%
100 $11,000
Q4 2022

Feb 14, 2023

BUY
$84.98 - $122.67 $509 - $736
6 Added 6.0%
106 $12,000
Q2 2022

Aug 15, 2022

BUY
$67.99 - $132.89 $5,099 - $9,966
75 Added 300.0%
100 $7,000
Q1 2022

May 16, 2022

BUY
$94.08 - $130.2 $2,352 - $3,254
25 New
25 $13,000
Q1 2022

May 13, 2022

SELL
$94.08 - $130.2 $2,352 - $3,254
-25 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$129.87 - $162.82 $3,246 - $4,070
25 New
25 $13,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $43.8B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Ancora Advisors, LLC Portfolio

Follow Ancora Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ancora Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ancora Advisors, LLC with notifications on news.